news
CMS, FDA fast-track breakthrough device coverage
The Centers for Medicare & Medicaid Services (CMS) and FDA are pushing a new RAPID pathway to speed up coverage for breakthrough medical devices. This means new tech could get to patients faster, especially in areas like health monitoring and diagnostics.
The Centers for Medicare & Medicaid Services (CMS) and FDA are pushing a new RAPID pathway to speed up coverage for breakthrough medical devices. This means new tech could get to patients faster, especially in areas like health monitoring and diagnostics.
The architecture take
The government says they want innovative health tech to reach people faster, which sounds great. But the real game here is getting these new devices covered by insurance, which is always the biggest bottleneck. The RAPID pathway is about accelerating reimbursement for FDA-approved 'breakthrough' devices, not just the approval itself. This is huge for wearables and other diagnostics that promise to shift care from clinics to daily life. It means less time waiting for tech that measures, say, your sleep architecture or heart rate variability to become affordable. I've watched so many promising tools get stuck in that loop. The push for this kind of policy shows a top-down recognition that continuous monitoring and personalized data are becoming essential, even if it feels like a slow roll. It's not about making shiny new gadgets; it's about getting vital data into bodies and routines.